Core Viewpoint - The company, Haijia Medical (06078), anticipates a revenue decline of approximately 9% to 10% for 2025, with projected revenues between RMB 4.0 billion and 4.05 billion [1] Financial Performance Summary - The expected net profit for 2025 is projected to be between RMB 1.4 billion and 2.0 billion, reflecting a significant decrease of approximately 66% to 76% primarily due to goodwill impairment [1] - Adjusted net profit is forecasted to be between RMB 4.5 billion and 4.9 billion, indicating a year-on-year decline of about 19% to 25% [1] - The net cash generated from operating activities is expected to be between RMB 9.4 billion and 10.0 billion, showing an increase of approximately 33% to 41% year-on-year [1] Factors Influencing Performance - The decline in revenue, net profit, and adjusted net profit is attributed to industry and macroeconomic impacts, as well as increased startup costs and depreciation expenses from newly opened hospitals [1] - The net profit decrease for the year ending December 31, 2025, is also significantly influenced by the goodwill impairment provision related to Etern Group Ltd. [1] - The company has conducted a careful assessment of its operational and financial performance, as well as the future prospects of its business, to determine the necessity and amount of the impairment and provision [1]
海吉亚医疗(06078)发盈警 预期2025年净利润约为1.4–2.0亿元 同比下降约66%至76%